Conceptus cuts Q4 revenue outlook. Affymax names new CEO. Print E-mail
By Staff   
Thursday, 06 January 2011 20:42
Below is a look at some of the headlines for companies that made news in the healthcare sector on January 6, 2011.

Conceptus Inc (NASDAQ:CPTS) cut its fourth-quarter revenue outlook citing a fall in sales of its birth-control device Essure.  For the quarter, the company now sees revenue of $36.3-$36.6 million. In October, it had forecast revenue of $39-$41 million.  Shares drop 6% after market closes after lossing about 4% since the company reported quarterly results in October.

Affymax Inc, (NASDAQ:AFFY) , has named John Orwin, currently the company's COO, to replace Arlene Morris as chief executive officer.  Affymax is expected to file with the FDA for approval of its experimental anemia drug in the second quarter.

Also Thursday:

Amarin Corporation plc (Nasdaq:AMRN) (the "Company"), a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today announced the pricing of an underwritten public offering of 12,000,000 American Depositary Shares ("ADSs") at a price to the public of $7.60 per ADS.

Amgen (Nasdaq:AMGN) and Xencor, Inc. announced today that they will collaborate to develop XmAb®5871, an Fc- engineered monoclonal antibody dually targeting CD19 and CD32b.  XmAb5871 is currently in late-stage preclinical development for the treatment of autoimmune diseases.  

Anthera Pharmaceuticals, Inc. (Nasdaq:ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced Paul F. Truex, Anthera's President and Chief Executive Officer, will present at the 29th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Thursday, January 13, 2011, at approximately 11:00 am Pacific Time.

Ardea Biosciences, Inc. (Nasdaq:RDEA) today announced positive, preliminary, top-line results from its Phase 2b study of RDEA594 in combination with the current standard of care for the treatment of gout, allopurinol.

Arena Pharmaceuticals, Inc. (Nasdaq:ARNA) announced today that the company is scheduled to present at the 29th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2011, at 4:00 p.m. Pacific Time (7:00 p.m. Eastern Time) at the Westin St. Francis Hotel in San Francisco, California.

Biodel Inc. (Nasdaq:BIOD) today announced that Dr. Errol De Souza, President and CEO of Biodel, will present a corporate update at the 29th Annual JPMorgan Healthcare Conference on Thursday, January 13, 2011 at 9:30 a.m. Pacific Time (12:30 p.m. Eastern Time).

BioNeutral Group, Inc. (OTC Bulletin Board:BONU), a specialty life science technology-based company, today announced it has received correspondence from KHA Solutions Group following a December 2010 meeting in Kentucky.

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) is pleased to announce the addition of Joey Jacobs to its Board of Directors.

Dendreon Corporation (Nasdaq:DNDN) management will host a conference call on Friday, January 7, 2011 at 9:00 a.m. ET to provide updates on U.S. commercialization progress, European strategy for PROVENGE, and pipeline progress.

Diagnostic Imaging International Corp. (OTCBB:DIIG) announced today that its wholly-owned subsidiary, Canadian Teleradiology Services ("CTS"), signed a contract with a network of hospitals to provide teleradiology services.

DK Sinopharma, Inc. (OTC Bulletin Board:DKSP) ("DK Sinopharma" or the "Company") reviewed the honors received in the year of 2010 to celebrate the achievements and successes over the past year.

Today eHealth, Inc. (NASDAQ: EHTH), the leading online source of health insurance for individuals, families and small businesses, announced that it is offering individual and family health insurance plans from Blue Cross and Blue Shield of Florida through the company's primary retail website,

GeckoSystems Intl. Corp. (PINKSHEETS: GOSY) announced today that they have successfully negotiated a Memorandum of Understanding (MOU) with FLAGMAN GRUPP LTD., in Tallinn, Estonia, enabling the first EU elder care robot trials.

Genesis Biopharma, Inc. (OTC Bulletin Board:GNBP), a biotechnology company developing targeted cancer therapies, announces that CEO Robert Brooke will present a company overview at the Biotech Showcase™ 2011 conference on Wednesday, January 12, 2011, at 9:45 a.m. Pacific time.  

Given Imaging (NASDAQ: GIVN) today announced that Homi Shamir, President and CEO, will now present at the 29th Annual J.P. Morgan Healthcare Conference on Thursday, January 13th at 7:30 a.m. PT, 10:30 a.m. ET.

Hansen Medical, Inc., (NASDAQ: HNSN), a global leader in flexible robotics and the developer of robotic technology for accurate 3D control of catheter movement, today announced it will showcase its new Lynx™ Robotic Ablation Catheter and other innovative new products at the 16th Annual Boston Atrial Fibrillation Symposium from January 13-15 at the Seaport Hotel and World Trade Center in Boston.

Hiru Corporation (PINK SHEETS:HIRU) announce that the management of its main subsidiary Shuangshi AHP decided to enhance the company's decision making and teamwork abilities.

International Monetary Systems, Ltd. (OTCBB: ITNM)
, a worldwide leader in business-to-business barter services, today announced the launching of a new medical benefits program for its nationwide clients.

IRIDEX Corporation (Nasdaq:IRIX) today announced that management will present at the OneMedForum San Francisco 2011 Conference at 8:45 a.m. PST on Tuesday, January 11.  

Korn/Ferry International (NYSE:KFY), a premier global provider of talent management solutions, today announced that Paul Pospisil, Ph.D. has joined the Firm as a Senior Client Partner in the Biotechnology and Life Sciences Practice.  He will be based out of the Firm's New York office.

MMRGlobal, Inc. (OTCBB:MMRF) ("MMR") today announced it has deployed the first of its kind proprietary health information and communications network in support of its MyMedicalRecords Personal Health Record and MMRPro products and services for healthcare professionals.

Neogen Corporation (Nasdaq:NEOG) announced today that it has named Steven J. Quinlan as the Company's chief financial officer to replace the retiring Richard Current. Current will immediately relinquish his responsibilities as CFO, but will remain with Neogen through the end of the fiscal year, May 31.

NMT Medical, Inc. (NASDAQ: NMTI) today announced that it has entered into a credit agreement with LSQ Funding Group, L.C., a Florida-based firm that specializes in providing financing to small- and medium-sized businesses.

Nutrastar International Inc. (OTC Bulletin Board:NUIN), a leading producer and supplier of premium branded Traditional Chinese Medicine ("TCM") consumer products, today announced that the Company will be participating in the upcoming Cowen and Company 9th Annual Consumer Conference being held at the Westin New York at Times Square (270 West 43rd Street) in New York City on January 10 – 11th, 2011.

NuVim, Inc. (PINKSHEETS: NUVM), a leading provider of refrigerated and shelf stable ready-to-drink healthy beverages and powder mixes, announced today that it has signed an agreement with Paul B. Addis, Ph.D., to research the additional health benefits consumers are citing in testimonials of how NuVim is helping them in their daily activities.

Orexigen® Therapeutics, Inc. (Nasdaq:OREX), a biopharmaceutical company focused on the treatment of obesity, today announced that the Company will be speaking at the JP Morgan Healthcare Conference.

Pacific Biomarkers, Inc. (OTCBB:PBMC), a provider of biomarker laboratory services to the pharmaceutical, biotechnology and diagnostics industries, announced that it has noted, with great interest, the publication of new studies suggesting that a simple urine test could help prevent cases of kidney failure.

Regenicin's (OTC Bulletin Board:RGIN) Chief Operating Officer, Chris Hadsall, recently received the 2010 Citizenship Award for his volunteer work with the VET Foundation and disabled veterans. Mr. Hadsall received the award at the VFW's 111th Annual Founders Day Banquet in December.  Hadsall joins a long list of notable citizens and groups bettering the lives of Veterans in the Colorado community.

SeraCare Life Sciences, Inc. (Nasdaq:SRLS), a global life sciences company providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics, today announced that it has entered into a loan agreement that provides senior secured credit facilities in the aggregate amount of $20.0 million with Middlesex Savings Bank and Commerce Bank and Trust Company.

Stellar Pharmaceuticals Inc. (OTCBB:SLXCF), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets, announces the approval by the Korean Food and Drug Administration ("KFDA") of one of the Company's lead products, Uracyst® (a sterile sodium chondroitin sulfate solution, 2%) for the treatment of interstitial cystitis / painful bladder syndrome ("IC/PBS").

Sun Healthcare Group, Inc. (NASDAQ: SUNH) today reaffirmed its 2010 EBITDAR guidance and is establishing its outlook for 2011.

Unity Management Group, Inc. (PINKSHEETS:UYMG), a Health Resource Company specializing in Physician and Hospital Practice Management, Medical Discount Plans, Business Services, Billing Software and Technologies, along with Pharmacy Instrumentation, and Calibration.

David H. Fater, CEO of Vicor Technologies, Inc. (OTCBB:VCRT), today announced that Thomas J. Bohannon, Chief Accounting Officer, has been appointed to serve as Vicor's Chief Financial Officer, effective as of January 1, 2011.

World Health Energy Holdings, Inc. (PINKSHEETS: WHEN), a public holding company operating in the alternative energy sector, announced today that the company's wholly-owned subsidiary, GNE-India, has signed a letter of intent with David Lobo from Deejay Coconut Farm PVT via a joint venture to build a 250-acre commercial algae farm in Bangalore, Indiato produce fish feed and Algal Oil.

"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit!! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!

blog comments powered by Disqus